Search results
Foghorn Therapeutics Shifts Focus from Development Of Cancer Hopeful with Eye Cancer
Benzinga via Yahoo Finance· 10 months agoFoghorn Therapeutics Inc (NASDAQ: FHTX) announced the data from the Phase 1 dose escalation safety...
IDEAYA Shares Jump On Positive Interim Data From Eye Cancer Trial
Benzinga via Yahoo Finance· 2 years agoThe shares of oncology-focused Ideaya Biosciences Inc (NASDAQ: IDYA) are trading higher after...
Eye cancer patient says life-saving treatment she needs isn’t on NHS: ‘I am devastated’
The Independent via Yahoo News· 1 year agoA woman with a rare form of cancer has shared her fears that she has a lower chance of survival...
New study offers hope for a rare and devastating eye cancer
Washington Post via Yahoo News· 3 weeks agoAfter more than a decade studying a rare eye cancer that produces some of the hardest-to-fight...
IDEAYA Biosciences Touts Encouraging Data From Combo Therapy For Rare Eye Cancer Impacting Around...
Benzinga via Yahoo Finance· 1 year agoIDEAYA Biosciences Inc (NASDAQ: IDYA) announced further interim results from its Phase 2 clinical...
Delcath Systems, Inc. (NASDAQ:DCTH) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoDelcath Systems, Inc. (NASDAQ:DCTH) Q3 2023 Earnings Call Transcript November 13, 2023 Operator:...
Delcath Systems Stock Jumps After Data Update From Eye Cancer Trials At ASCO Meeting
Benzinga via Yahoo Finance· 2 years agoDelcath Systems Inc (NASDAQ: DCTH) announced further details regarding presentations relating to its...
Red spot in dad's eye turns out to be sign of rare cancer
Yahoo Life UK· 4 days agoTony Brown spotted a red spot in his eye, which turned out to be a sign of a rare cancer. (Suzie...
Why IBD Stock Of The Day Immunocore Has Rocketed 233% Since January
Investor's Business Daily· 1 year agoImmunocore is the IBD Stock Of The Day as expectations for triple-digit sales growth and future...
Immunocore Holdings PLC Reports Q1 2024 Earnings: Misses EPS Estimates, Surpasses Revenue Forecasts
GuruFocus.com via Yahoo Finance· 4 days agoRevenue: Reported $70.3 million in Q1 2024, up 36% from $51.6 million in Q1 2023, falling short of...